ViroCell Biologics completed an oversubscribed convertible note offering led by First Light Asset Management LLC to accelerate its growth in viral vector manufacturing services.
ViroCell Biologics completed an oversubscribed convertible note offering led by First Light Asset Management LLC to accelerate its growth in viral vector manufacturing services.
08/14/24, 11:25 AM
Location
londonInvestors
Dorset Opportunity Fund Lp, Sartorius Stedim Biotech S.A., First Light Asset Management Llc
ViroCell Biologics has successfully completed an oversubscribed financing round through a convertible note offering. The proceeds will be used to accelerate ViroCell's growth amid strong demand for its specialized services in viral vector design and manufacturing.
Company Info
Location
vestry house
london, england, united kingdom
Additional Info
ViroCell Biologics is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials.